By Farah Master HONG KONG (Reuters) - If investors in China's biotech industry needed one more sign that the sector is coming of age, then a major licensing deal RemeGen Co Ltd...
(Reuters) -U.S. health regulators have approved Roche's arthritis drug Actemra for emergency use to treat hospitalized COVID-19 patients, giving an extra boost to a medicine that...
ZURICH (Reuters) - Roche (S:ROG) said any lingering affects of a logistics glitch in Britain should be "cleared out" by the weekend, after the Swiss drugmaker delivered 80 tonnes...
As we approach the 2020 election, you must be wondering: how will the elected candidate impact the stock market and certain key stocks in particular?Experience tells us that it is...
European shares were slightly lower on Thursday morning as traders sit on their hands ahead of the latest ECB meeting amid well-received earnings from German automaker Daimler...
Europe The start of the second full week of 2015 got a bit choppy as recent volatility has left markets unsure which way to go. Shares initially weathered the storm of falling oil...
Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in Switzerland, Germany, the United States, Austria, Netherlands, the United Kingdom, France, Belgium, and internationally. The company offers pharmaceutical products for treating oncology, neuroscience, infectious, immunology, cardiovascular and metabolism, ophthalmology, and respiratory, as well as anemia, cancer, dermatology, hemophilia, inflammatory and autoimmune, neurological, and transplantation. It also offers in vitro tests for the diagnosis of various diseases, such as cancer, diabetes, Covid-19, hepatitis, human papillomavirus, and other diseases. In addition, the company supplies diagnostic instruments and reagents. The company was founded in 1896 and is headquartered in Basel, Switzerland.
Type | 5 Min | 15 Min | Hourly | Daily | Monthly |
|---|---|---|---|---|---|
| Moving Averages | Strong Buy | Strong Buy | Strong Buy | Neutral | Neutral |
| Technical Indicators | Strong Buy | Strong Buy | Strong Buy | Strong Buy | Strong Sell |
| Summary | Strong Buy | Strong Buy | Strong Buy | Buy | Sell |
Name | Last | High | Low | Chg. | Chg. % | Vol. | Time | ||
|---|---|---|---|---|---|---|---|---|---|
| 38.25 | 38.25 | 38.25 | 0.00 | 0.00% | 4.44K | London | |||
| 1,020.50 | 1,026.00 | 995.20 | +0.50 | +0.05% | 2.39M | London | |||
| 320.00 | 325.00 | 311.50 | +5.00 | +1.59% | 1.04M | London | |||
| 1,102.00 | 1,117.00 | 1,091.50 | -6.50 | -0.59% | 1.07M | London | |||
| 2,342.00 | 2,342.00 | 2,300.00 | -10.00 | -0.42% | 124.52K | London | |||
| 111.20 | 117.80 | 111.20 | -1.60 | -1.42% | 501.38K | London | |||
| 74.80 | 76.50 | 74.70 | +0.30 | +0.40% | 292.33K | London | |||
| 729.20 | 734.60 | 707.00 | +13.80 | +1.93% | 1.47M | London | |||
| 168.20 | 169.80 | 168.20 | -1.80 | -1.06% | 83.27K | London | |||
| 477.10 | 482.90 | 470.90 | +2.50 | +0.53% | 3.93M | London | |||
| 1,830.00 | 1,902.00 | 1,808.00 | +8.00 | +0.44% | 48.15K | London | |||
| 19.75 | 20.00 | 19.50 | 0.00 | 0.00% | 0.00 | London | |||
| 254.80 | 257.00 | 253.30 | -0.70 | -0.27% | 9.47M | London | |||
| 57.00 | 57.00 | 57.00 | +2.00 | +3.64% | 121.34K | London | |||
| 352.50 | 352.50 | 352.50 | 0.00 | 0.00% | 2.77K | London |